Sponsored by
pharmaceutical companies

pharmaceutical companiesRSS

Analysis

Dangerous counterfeit drugs are putting millions of U.S. consumers at risk

19 million Americans obtained likely counterfeit prescription medications through non-licensed internet pharmacies or while traveling - but while counterfeit medications may look legitimate, active ingredients are frequently replaced with dangerous alternatives.... Read more»

Stiff fentanyl sentences in Arizona would target users, not just dealers, critics say

A GOP plan to impose stiff prison sentences against those who make and sell fentanyl is more likely to sweep up drug addicts than the dealers it ostensibly seeks to punish, critics said Thursday. ... Read more»

Biden’s big social spending bill caught in snags in the Senate

President Joe Biden’s giant social and climate spending bill on Thursday night appeared stalled in the U.S. Senate for some time to come, a deep frustration for congressional Democrats who aimed to pass the ambitious package by the Christmas recess. ... Read more»

Despite restraints, Democrats’ drug pricing plan could still aid consumers

The Medicare prescription drug pricing plan Democrats unveiled this week is not nearly as ambitious as many lawmakers sought, but they and drug policy experts say the provisions crack open the door to reforms that could have dramatic effects. ... Read more»

Pharma campaign cash delivered to key lawmakers with surgical precision

The Biden administration and Congress are embroiled in haggling over what priorities will make it into the spending bill, but for the pharmaceutical industry there is one agenda: Heading off Medicare drug price negotiation, which it considers an threat to its business model.... Read more»

Public backs Medicare prescription price negotiation even after hearing both sides’ views

As Congress debates cutting prescription drug costs, a poll released Tuesday found the majority of adults — regardless of political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.... Read more»

FactCheck: An ad’s charge that price haggling would 'swipe $500 billion from Medicare' is incorrect

The 60 Plus Association ran an ad that claimed Medicare drug price negotiations were “swiping” $500 billion from Medicare and going to be used to “cut benefits and no longer pay for lifesaving medicines" - while the $500 billion number is based on facts, everything else is misleading.... Read more»

FactCheck: Q&A on coronavirus vaccines

An overview of the vaccine development efforts underway and answer some questions about the testing process, the likelihood and timing of a vaccine in the U.S., and what to expect from a COVID-19 vaccine.... Read more»

Sinema's campaign a favorite for big pharma donations

Sen. Kyrsten Sinema formed a congressional caucus to raise “awareness of the benefits of personalized medicine” in February. Soon after that, employees of pharmaceutical companies donated $35,000 to her campaign committee.... Read more»

Public health vs. parent choice: The vaccination debate in Arizona

Health officials warn that vaccination rates are deteriorating across Arizona, risking public health as parents continue to opt out of immunizations.... Read more»

Generic drug prices are declining, but many consumers aren’t benefiting

Outcry has been building over the rising cost of brand-name medications, but the price of generic drugs has been moving in the opposite direction. The stock prices of generic manufacturers have tumbled, but many consumers aren’t paying less at the pharmacy counter. ... Read more»

Big data + Big pharma = Big money

Need another reminder of how much drugmakers spend to discover what doctors are prescribing? Look no further than new documents from the leading keeper of such data. ... Read more»

Medicare’s failure to track doctors wastes billions on name-brand drugs

Medicare is wasting hundreds of millions of dollars a year by failing to rein in doctors who routinely give patients pricey name-brand drugs when cheaper generic alternatives are available.... Read more»

American Pain Foundation

Pain advocacy group shuts down as senators launch painkiller probe

A leading pain advocacy organization shuts down ahead of an investigation launched by the Senate Finance Committee into makers of narcotic painkillers and groups that champion them. ... Read more»

Express Scripts CEO calls Az site critical to company

Express Scripts' CEO said Tuesday that the company's 1,700-worker Tempe site is "critical" to the pharmaceutical benefits manager, which is in the midst of a $29.1 billion bid to purchase its biggest rival.... Read more»